Skip to main content

Table 2 Agreement with statements on screening coverage and indications in rounds 1 and 2

From: A modified Delphi study of screening for fetal alcohol spectrum disorders in Australia

Statement

R1 N

R1 % Agree(IQD)

R2 % Agree(IQD)

Screening coverage

   

1. Screening for FASD at birth should be universal

87

58 (3)

55 (3)

2. Screening for FASD at birth should be targeted

88

68 (2)

76 (1)

3. Screening for FASD in childhood should be universal

86

49 (3)

40 (2)

4. Screening for FASD in childhood should be targeted

86

78 (1)

84 (1)

Indications for targeted screening - presentations

   

5. an alcohol-related event, illness or dependency in the birth mother

91

96 (1)

-

6. a parent/foster parent who is concerned that their child might have a FASD

91

99 (1)

-

7. prenatal alcohol exposure

90

92 (1)

-

8. developmental delay

88

91 (1)

-

9. growth retardation or failure to thrive

87

91 (1)

-

10. structural central nervous system abnormalities

82

87 (1)

-

11. neurological signs

84

82 (1)

-

12. functional central nervous system abnormalities

84

88 (1)

-

13. characteristic FAS facial anomalies

89

97 (1)

-

14. birth defects

85

93 (1)

-

15. reported or observed problems with behaviour

88

86 (1)

-

Indications for targeted screening – high risk groups

   

16. children of mothers attending alcohol treatment services

91

93 (1)

-

17. siblings of identified cases of FASD

90

96 (1)

-

18. children who are diagnosed with ADHD

82

74 (2)

-

19. children entering a child development service

89

87 (1)

-

20. children entering child protection

86

85 (1)

-

21. children entering foster care or adoptive placements (incl. kinship care)

86

87 (1)

-

22. children entering a juvenile justice setting

84

82 (1)

-

  1. R1-Round 1; R2-Round 2; IQD-inter-quartile deviation.
  2. Includes responses ‘agree’ and ‘strongly agree.’
  3. Results for statements that reached 70% agreement (consensus) are presented in bold.